Home

previzualizare gunoi Cinci laboratory markers of cognitive dysfunction Lovitura hârâit Fotoliu

PDF) Mild cognitive impairment (part 1): Clinical characteristics and  predictors of dementia | ResearchGate
PDF) Mild cognitive impairment (part 1): Clinical characteristics and predictors of dementia | ResearchGate

Post-Stroke Cognitive Impairment and Dementia | Circulation Research
Post-Stroke Cognitive Impairment and Dementia | Circulation Research

Evaluation of Suspected Dementia | AAFP
Evaluation of Suspected Dementia | AAFP

A Clinical Approach to Mild Cognitive Impairment | American Journal of  Psychiatry
A Clinical Approach to Mild Cognitive Impairment | American Journal of Psychiatry

Rapidly progressive dementias — aetiologies, diagnosis and management |  Nature Reviews Neurology
Rapidly progressive dementias — aetiologies, diagnosis and management | Nature Reviews Neurology

Frontiers | Blood-Based Biomarkers for Predictive Diagnosis of Cognitive  Impairment in a Pakistani Population
Frontiers | Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population

Frontiers | Validity Evidence for the Research Category, “Cognitively  Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and  Alzheimer's Disease
Frontiers | Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer's Disease

DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The  Journal of Prevention of Alzheimer's Disease
DIAGNOSIS OF EARLY ALZHEIMER'S DISEASE: CLINICAL PRACTICE IN 2021 • The Journal of Prevention of Alzheimer's Disease

Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A  systematic review and meta-analysis - ScienceDirect
Retinal biomarkers in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis - ScienceDirect

Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360

Modified Mediterranean-ketogenic diet modulates gut microbiome and  short-chain fatty acids in association with Alzheimer's disease markers in  subjects with mild cognitive impairment - eBioMedicine
Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer's disease markers in subjects with mild cognitive impairment - eBioMedicine

Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ  from Alzheimer's Disease | Journal of Neuroscience
Neurophysiological and Brain Structural Markers of Cognitive Frailty Differ from Alzheimer's Disease | Journal of Neuroscience

IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of  Mild Cognitive Impairment | HTML
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML

Chronic Kidney Disease: Cognitive Dysfunction in Chronic Kidney Disease -  Renal and Urology News
Chronic Kidney Disease: Cognitive Dysfunction in Chronic Kidney Disease - Renal and Urology News

Cognitive dysfunction in diabetes: how to implement emerging guidelines |  SpringerLink
Cognitive dysfunction in diabetes: how to implement emerging guidelines | SpringerLink

Type 2 diabetes and cognitive dysfunction—towards effective management of  both comorbidities - The Lancet Diabetes & Endocrinology
Type 2 diabetes and cognitive dysfunction—towards effective management of both comorbidities - The Lancet Diabetes & Endocrinology

IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of  Mild Cognitive Impairment | HTML
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML

The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive  dysfunction—towards effective management of both comorbidities  https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ"  / Twitter
The Lancet Diabetes & Endocrinology on Twitter: "Type 2 #diabetes and #cognitive dysfunction—towards effective management of both comorbidities https://t.co/Mw67WhHQza #dementia #cognition #T2D https://t.co/pdenvnIfsJ" / Twitter

IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of  Mild Cognitive Impairment | HTML
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment | HTML

Differentiating amnestic from non-amnestic mild cognitive impairment  subtypes using graph theoretical measures of electroencephalography |  Scientific Reports
Differentiating amnestic from non-amnestic mild cognitive impairment subtypes using graph theoretical measures of electroencephalography | Scientific Reports

Frontiers | Blood-Based Biomarkers for Predictive Diagnosis of Cognitive  Impairment in a Pakistani Population
Frontiers | Blood-Based Biomarkers for Predictive Diagnosis of Cognitive Impairment in a Pakistani Population

Using a Digital Neuro Signature to measure longitudinal individual-level  change in Alzheimer's disease: the Altoida large cohort study | npj Digital  Medicine
Using a Digital Neuro Signature to measure longitudinal individual-level change in Alzheimer's disease: the Altoida large cohort study | npj Digital Medicine

Prediction of cognitive impairment via deep learning trained with  multi-center neuropsychological test data | BMC Medical Informatics and  Decision Making | Full Text
Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data | BMC Medical Informatics and Decision Making | Full Text

Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360
Diagnosis and Treatment of Mild Cognitive Impairment | Consultant360